Table 2 Clinical Outcomes of Treg cell infusion within renal transplant recipients.
Subject # | Date of | Cell # Administered (×109) | Biopsy at | DSA at | Graft loss at | |||||
|---|---|---|---|---|---|---|---|---|---|---|
Transplant | Treg infusion | 3 months | 1 year | 3 months | 1 year | 2 years | 1 year | 2 years | ||
1 | 7/10/14 | 9/8/2014 | 0.5 | NR | NR | − | + | + | NO | NO* |
2 | 8/7/14 | 10/6/2014 | 0.5 | NR | NR | − | − | − | NO | NO |
3 | 8/29/14 | 10/28/2014 | 0.5 | NR | NR | − | − | − | NO | NO |
4 | 9/22/14 | 11/21/2014 | 1.0 | NR | NR | − | − | − | NO | NO |
5 | 12/4/14 | 2/2/2015 | 1.0 | NR | NR | − | − | − | NO | NO |
6 | 1/8/15 | 3/9/2015 | 1.0 | NR | NR | − | − | − | NO | NO |
7 | 2/2/2015 | 4/3/2015 | 5.0 | NR | NR | − | − | − | NO | NO |
8 | 3/27/2015 | 5/26/2015 | 5.0 | NR | SCR C4d+ | − | + | + | NO | NO |
9 | 4/23/2015 | 6/22/2015 | 5.0 | NR | NR | − | − | − | NO | NO |
